CAR-T疗法诞生以来，安全性一直是悬在头上的达摩克利斯之剑。CRS、ICANS以及长期安全信号，是无法逃避的话题。日前，FDA的几位高管在Annals of Interal Medicine上发表的一篇文章很好地阐述了他们的立场：将以灵活的监管方法支持这些新型细胞疗法的开发。
���������X�g���[�W�̋}���ȉ��i�����Ƌ����s�����������Ă��܂��B�����APC�p�[�c���v���ʍ��Y�Ƃ��Ď����������\�������鍡�A���߂ɋN�����C���V�f���g�����M�҂��������ꖕ�̕s���Ƃ́B
。关于这个话题，体育直播提供了深入分析
Continue reading...
FT Edit: Access on iOS and web
“Based on the New Yorker article, we made the decision to add a correction notice to all 138 publications drawing attention to CPSP studies and surveys to clarify that the cases are fictional,” Joan Robinson, editor-in-chief of Paediatrics & Child Health, told Retraction Watch. “From now on, the body of the case report will specifically state that the case is fictional.”